Severe aortic stenosis, left untreated and symptomatic, carries a grim timeline: most people die within two to three years of developing symptoms, and five-year mortality reaches somewhere between 60 and 90 percent without intervention.1PubMed Central. Unoperated severe aortic stenosis: decision making in an adult UK-based population2PubMed Central. Aortic Valve Interventions in Asymptomatic Severe Aortic Stenosis: Who, Why, and When? That range is wide because survival depends heavily on whether you have symptoms, what type of treatment you receive, and what other health conditions you carry. The picture after valve replacement is dramatically different, but even that answer comes with important caveats.
What Happens Without Treatment
The natural history of severe aortic stenosis follows a pattern that cardiologists have tracked for decades. The valve narrows gradually, and for a while the heart compensates by thickening its walls and pumping harder. People can feel fine during this phase. But once symptoms appear, the decline is steep. The classic warning signs are chest pain with exertion, fainting spells, and shortness of breath from heart failure. After those symptoms set in, average survival without surgery drops to roughly two to three years.3PubMed Central. Management of Asymptomatic Severe Aortic Stenosis
A large study tracking nearly 600,000 patients with varying degrees of aortic stenosis put numbers on the full spectrum. Over four years, untreated severe aortic stenosis carried roughly a 45 percent all-cause mortality rate. For comparison, people with no stenosis had about a 14 percent rate over the same period.4PubMed. The Mortality Burden of Untreated Aortic Stenosis In the landmark PARTNER I trial, patients with severe symptomatic aortic stenosis who were considered too high-risk for surgery and did not receive any valve intervention had a five-year mortality rate of 94 percent. That number, while drawn from a particularly sick group, illustrates just how lethal advanced disease becomes without treatment.
If You Have No Symptoms Yet
Being told you have severe aortic stenosis but feel perfectly fine puts you in a complicated category. The condition progresses at different speeds in different people. On average, the valve opening shrinks a little each year, but there is enormous variation.3PubMed Central. Management of Asymptomatic Severe Aortic Stenosis Some people remain symptom-free for years; others progress quickly. The traditional approach has been “watchful waiting,” monitoring with regular echocardiograms and holding off on surgery until symptoms develop or the heart shows signs of weakening.
That conventional wisdom is being challenged. A randomized trial published in the New England Journal of Medicine compared early surgery to conservative care in people with asymptomatic severe aortic stenosis. Death from any cause occurred in about 7 percent of the early-surgery group versus 21 percent in the conservative-care group, a substantial difference.5PubMed. Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis A meta-analysis pooling several studies found early valve replacement was associated with a much lower risk of death compared to watchful waiting.6Structural Heart. Early Aortic Valve Replacement versus Watchful Waiting in Asymptomatic Severe Aortic Stenosis: A Study-Level Meta-Analysis Still, these results have to be weighed against the risks of surgery itself, and a review of the evidence notes that procedural complications remain a real concern when operating on people who currently feel well.7PubMed Central. Comparing Early Intervention to Watchful Waiting: A Review on Risk Stratification and Management in Asymptomatic Aortic Stenosis
To help sort out who benefits from early intervention, doctors are turning to stress tests and blood markers. Exercise stress echocardiography can unmask problems that do not show up at rest, such as a spike in blood pressure across the valve or reduced exercise capacity. These findings have repeatedly proven to be strong predictors of who will run into trouble.8PubMed Central. The Prognostic Value of Exercise Stress Echocardiography in Asymptomatic Moderate and Severe Aortic Stenosis: A Systematic Review of Stress-Derived Hemodynamic and Functional Markers BNP, a blood protein that rises when the heart is under strain, has also emerged as a useful tool. Asymptomatic patients with low BNP levels had only about a 2 percent event rate at one year, while those with the highest levels faced vastly higher rates of valve-related death or heart failure hospitalization.9PubMed. B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis
The Risk of Sudden Death
One of the most frightening aspects of severe aortic stenosis is the possibility of sudden cardiac death, sometimes with no preceding symptoms at all. A large Japanese registry found that about 7 percent of asymptomatic patients experienced sudden death over five years, roughly 1.4 percent per year. Among those who died suddenly, two-thirds had no warning symptoms beforehand, and most of those deaths occurred within three months of a clinical visit where they had appeared stable.10PubMed Central. Sudden Death in Patients With Severe Aortic Stenosis: Observations From the CURRENT AS Registry Risk factors for sudden death in that study included being on dialysis, a history of heart attack, low body mass index, very high peak valve velocity, and reduced heart pump function.
A European study found a somewhat lower rate, about 0.4 percent per year among asymptomatic patients overall, with the rate ticking up slightly to 0.6 percent per year after the stenosis reached the severe range. Older age, a thicker heart muscle, and lower body weight were independent risk factors.11Heart. Sudden cardiac death in asymptomatic patients with aortic stenosis The discrepancy between the two registries likely reflects differences in patient populations and how sudden death was classified, but both make the same basic point: sudden death in asymptomatic severe aortic stenosis is uncommon on a per-year basis but not negligible, and it is hard to predict at the individual level.
How Valve Replacement Changes the Timeline
Getting a new valve, whether through open-heart surgery (surgical aortic valve replacement, or SAVR) or a catheter-based procedure (transcatheter aortic valve replacement, or TAVR), transforms the survival outlook. The question for many people is which procedure, and how long the benefit lasts.
A propensity-matched analysis found that five-year survival was not significantly different between SAVR and TAVR, with rates of roughly 63 percent and 60 percent respectively.12PubMed Central. Five-Year Survival After Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Valve Stenosis—Do We Choose the Right Treatment for Each Patient? The picture changes at longer time horizons. A 10-year follow-up of a registry study showed survival of about 37 percent after surgical replacement versus about 18 percent after catheter-based replacement, with the curves separating around three years after the procedure.13IJC Heart & Vasculature. Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study That gap reflects several factors: the TAVR population in these registries tends to be older and sicker at baseline, and there are unanswered questions about how long catheter-delivered valves last compared to surgically implanted ones.
An eight-year follow-up of early TAVR recipients with first-generation bioprosthetic valves showed a survival rate of about 30 percent, but the valve itself held up well in most survivors, with low rates of structural failure.14PubMed Central. Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement A modeling study estimated that for older patients, the durability difference between TAVR and surgical valves has little practical effect on life expectancy, because competing causes of death catch up first. For younger patients, though, even a moderate reduction in valve lifespan could meaningfully shorten life expectancy, making surgical replacement the better bet for people in their 40s, 50s, or early 60s.15PubMed. Impact of Transcatheter Aortic Valve Durability on Life Expectancy in Low-Risk Patients With Severe Aortic Stenosis
Low-Flow, Low-Gradient Aortic Stenosis
Not all severe aortic stenosis looks the same on an echocardiogram. A subtype called low-flow, low-gradient aortic stenosis is particularly tricky. In these patients, the valve area is severely narrowed but the pressure difference across the valve is not as high as expected, either because the heart is too weak to push hard enough or, paradoxically, because the heart is pumping a smaller volume despite technically normal squeezing function. Both forms carry a worse prognosis than the “classic” high-gradient version.
In patients with the paradoxical form (normal pump strength but low flow), untreated one-year mortality in the PARTNER trial was about 66 percent. TAVR cut that to 35 percent, a dramatic improvement, but outcomes were still worse than in patients with normal flow and high gradients.16PubMed. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis After surgical valve replacement, five-year survival was about 81 percent in paradoxical low-flow patients and 72 percent in those with weakened hearts, compared to 85 percent in patients with normal flow.17PubMed. Impact of classic and paradoxical low flow on survival after aortic valve replacement for severe aortic stenosis Early surgical mortality was also higher in both low-flow groups. Even after TAVR, patients with this variant were more likely to be hospitalized for heart failure and to remain in worse functional condition compared to those with normal-flow disease.18PubMed. Prognosis of paradoxical low-flow low-gradient aortic stenosis after transcatheter aortic valve replacement
If you have been told your severe aortic stenosis has “low gradients,” this is worth a detailed conversation with your cardiologist. The distinction matters because it affects both how urgently treatment is needed and how much benefit you can expect from intervention.
Kidney Disease, Frailty, and Other Conditions That Shorten the Timeline
Severe aortic stenosis rarely exists in isolation. Many patients are elderly and carry a burden of other conditions that affect how long they live, with or without valve treatment. Kidney disease stands out as one of the strongest modifiers. Among patients with severe aortic stenosis, five-year survival was about 71 percent in those with healthy kidneys but dropped to 54 percent with moderate kidney disease and just 34 percent with severe kidney disease.19PubMed Central. Severe Aortic Stenosis and Chronic Kidney Disease: Outcomes and Impact of Aortic Valve Replacement A separate study confirmed that worsening kidney function was independently linked to higher death rates.20Journal of the American Heart Association. Characteristics and outcomes of patients with aortic stenosis and chronic kidney disease In patients on dialysis, aortic stenosis acts as an independent predictor of death on top of the already high baseline mortality that dialysis patients face.21PubMed Central. Aortic Stenosis in End-Stage Renal Disease: Incidence, Prevalence, and Mortality in a National Korean Cohort
Frailty, a clinical syndrome of weakness, exhaustion, and slow walking speed common in older adults, also matters. A study that tailored treatment based on frailty assessments found that at six years, overall survival was about 40 percent, but pre-frail patients did significantly better than those who were already frail. Patients who received TAVR also did better than those managed without intervention.22PubMed Central. Long-Term Outcome of Elderly Patients with Severe Aortic Stenosis Undergoing a Tailored Interventional Treatment Using Frailty-Based Management: Beyond the Five-Year Horizon These numbers reinforce a frustrating reality: the patients who would benefit most from a new valve are sometimes the ones least able to tolerate the procedure.
How People Actually Die from Severe Aortic Stenosis
Understanding the causes of death helps explain why the disease is so dangerous. In a study tracking mode of death among patients with severe aortic stenosis, heart failure was the single biggest killer, accounting for about a quarter of all cardiac deaths. Sudden death made up another 13 percent of cardiac deaths. On the non-cardiac side, infections and cancer were the leading causes, each also around 13 percent and 11 percent respectively.23PubMed Central. Causes of Death in Patients with Severe Aortic Stenosis: An Observational study Another study found that roughly 61 percent of deaths were cardiovascular, while 33 percent were non-cardiovascular.24PubMed. Causes of death and mortality and evaluation of prognostic factors in patients with severe aortic stenosis in an aging society
That non-cardiovascular fraction is worth pausing on. Because severe aortic stenosis is overwhelmingly a disease of older adults, many patients are simultaneously at risk of dying from cancer, pneumonia, or other age-related conditions. A new valve eliminates the cardiac threat but does nothing about the rest. This is part of why post-treatment survival statistics, especially at the 10-year mark, are shaped as much by patient age and overall health as by the valve procedure itself.
Sex Differences After Valve Replacement
Women tend to fare somewhat better than men after valve replacement, though the reasons are not fully understood. A study examining heart remodeling patterns in severe aortic stenosis found that women had better outcomes after TAVR, particularly among those whose hearts had developed a pattern called concentric hypertrophy, where the walls thicken symmetrically. The survival benefit of being female did not seem to be explained by differences in how the heart remodeled, suggesting other biological or hormonal factors are at play.25European Heart Journal. Sex differences in left ventricular remodeling in patients with severe aortic valve stenosis
Why Some People With Severe Aortic Stenosis Never Get Surgery
One of the most sobering findings in the literature is how many people with severe aortic stenosis never receive valve replacement. A UK study found that nearly half of patients with severe stenosis did not undergo surgery. The most common reason for not referring symptomatic patients was that they were judged too high-risk for the operation. Among asymptomatic patients, the most common reason was simply that they had no symptoms. Strikingly, only about one in five of the patients who did not have surgery had even been referred for a surgical opinion.1PubMed Central. Unoperated severe aortic stenosis: decision making in an adult UK-based population
The advent of TAVR has changed this landscape somewhat, since catheter-based procedures are less physically demanding than open-heart surgery. But gaps persist. Patients with kidney disease, for instance, are less likely to be referred for valve replacement despite the proven survival benefit.19PubMed Central. Severe Aortic Stenosis and Chronic Kidney Disease: Outcomes and Impact of Aortic Valve Replacement If you or a family member has been diagnosed with severe aortic stenosis and told that surgery is not an option, it is reasonable to ask whether TAVR has been specifically considered and whether a referral to a heart valve team is warranted.
Bicuspid Aortic Valves and Younger Patients
Most severe aortic stenosis is caused by age-related calcification of a normal three-leaflet valve. But about 1 to 2 percent of the population is born with a bicuspid aortic valve, which has only two leaflets instead of three. These valves tend to calcify and stiffen decades earlier, meaning some people develop severe stenosis in their 40s or 50s rather than their 70s or 80s.
The good news is that most people with a bicuspid valve do well. A long-term study found that survival among patients with the typical form of bicuspid valve disease was similar to the general population matched by age and sex.26PubMed. Bicuspid aortic valve: long-term morbidity and mortality The exception was a smaller subset with more complex anatomy involving additional congenital abnormalities, who did face a higher mortality risk. After surgery, relative survival among bicuspid valve patients was similar regardless of whether they were younger or older, or whether they also needed additional procedures like coronary bypass.27PubMed Central. Relative survival after aortic valve surgery in patients with bicuspid aortic valves For younger patients with bicuspid disease, mechanical valves, which require lifelong blood-thinning medication but can last a lifetime, are often preferred over bioprosthetic valves that may need replacement in 10 to 20 years.
Can You Exercise with Severe Aortic Stenosis?
If you have severe aortic stenosis and feel well, you might wonder whether physical activity is safe. This is an area where doctors have traditionally been cautious, advising patients to avoid vigorous exercise. A review of the available research found no evidence that supervised exercise under appropriate conditions caused dangerous drops in blood pressure or fatal events in older patients with severe stenosis.28PubMed Central. The safety of exercise for older patients with severe aortic stenosis undergoing conservative management: A narrative review That said, the review noted the absence of formal exercise intervention trials in this population, meaning the reassurance comes from stress testing data rather than from programs where patients actually exercised regularly over time.
Exercise stress testing itself is increasingly used not to determine if you can exercise safely, but to figure out how your valve disease is progressing. As noted earlier, abnormal responses during a stress test, like a big jump in the pressure difference across the valve, are among the best predictors of who will develop problems in the near future. So your doctor may recommend a stress test not because they are worried about the test harming you, but because the results will help decide whether it is time to intervene.
Screening and the Question of Early Detection
Because untreated symptomatic severe aortic stenosis is so lethal, there is growing interest in whether routine screening, for example with a stethoscope exam or echocardiogram in older adults, could catch the disease before it becomes dangerous. A cost-effectiveness analysis modeled screening at age 80 and found it was cost-effective by standard thresholds used in healthcare economics.29European Heart Journal – Quality of Care and Clinical Outcomes. Cost-effectiveness of population screening for aortic stenosis The gains were modest, adding a small amount to quality-adjusted life expectancy, but at a reasonable cost per unit of benefit. No country currently has a formal population-wide screening program for aortic stenosis, but the concept is gaining traction as TAVR makes treatment accessible to a wider range of patients who might previously have been considered too frail for open-heart surgery.
The practical implication for individuals is simpler: if you are over 65 and your doctor hears a heart murmur, an echocardiogram is warranted. Aortic stenosis is often found incidentally during imaging done for other reasons, and early identification allows monitoring that can catch progression before symptoms appear. Given the evidence that timely intervention can dramatically alter survival, a diagnosis made a few years earlier could make a meaningful difference in outcomes.